Genotype-phenotype Correlation and Pathogenic Mechanism in Hereditary Ataxia

NCT05160870 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2022-01-12

No results posted yet for this study

Summary

The investigators aimed to find appropriate biomarkers such as serum neurofilament light chain in reflecting disease severity in hereditary ataxia from a large cohort during long-term follow-up. The disease severity is indicated by clinical scales and brain MRI tests.

Conditions

  • Hereditary Ataxia

Sponsors & Collaborators

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-30
Primary Completion
2022-12-25
Completion
2025-12-25

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05160870 on ClinicalTrials.gov